AI-generated summary
In a study of streptozotocin-induced diabetic Wistar rats, the authors report that intravenous low-level laser irradiation at four wavelengths lowered measured interleukin levels compared with non-irradiated diabetic controls. They state that, at constant energy, shorter wavelengths such as blue (450 nm) appeared more effective than red (638 nm) or infrared (808 nm) light.
- Who or what was studied
- Diabetic Wistar rats induced with streptozotocin
- Wavelengths
- 808, 638, 532, 450 nm
- Limits stated in the abstract
- The abstract describes an animal study with no stated sample size and does not report statistical methods or effect sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on lasertherapyjournal.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 638 nm, 532 nm, 450 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.